ユーザーIDをお忘れですか? or パスワードをお忘れですか?

東京ビッグサイト | 有明

2018年11月11日 (日) 午前 9:30 - 2018年11月13日 (火) 午後 5:40

〒135-0063, 東京都江東区有明3-11-1



[V4-S6] Possibility of AI for Future New Drug Evaluation and Review Process

Session Chair(s)

Makoto  Suzuki, PhD

Makoto Suzuki, PhD

Director, Medical Writing

MSD K.K., Japan

Share what next innovation technology is available in global drug development, such as AI translation in the medical field using multi-language speech translation technology of Ministry of Internal Affairs and Communications, and discuss shortening of approval review period using innovation such as AI.


Eiichiro  Sumita, PhD

High Quality Automatic Translation By Using AI

Eiichiro Sumita, PhD

National Institute of Information and Communications Technology (NICT), Japan

NICT Fellow, Associate Director General of ASTREC

Kazuya  Obanayama

Development and Influence of Digital Technonlogy

Kazuya Obanayama

Bayer Yakuhin, Ltd., Japan

Digital Transformation Product Leader & PMO, Commercial Operations Management

Megumi  Sato

Creation of Package Inserts Post-Marketing Materials Using XML

Megumi Sato

MSD K.K., Japan

Sr, Specialist, Regulatory Operations